Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-26 Sale | 2026-01-26 5:05 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 647 | $492.42 | $318,596 | 1,108,244 (Indirect Direct) | View |
| 2026-01-20 Sale | 2026-01-20 5:46 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 2,238 | $490.77 | $1,098,343 | 1,108,891 (Indirect Direct) | View |
| 2026-01-09 Sale | 2026-01-13 4:38 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 240 | $550.33 | $132,080 | 1,111,129 (Indirect Direct) | View |
| 2026-01-09 Sale | 2026-01-13 4:34 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 18,410 | $522.4 | $9,617,312 | 1,111,369 (Indirect Direct) | View |
| 2025-12-10 Sale | 2025-12-12 4:35 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 18,650 | $552.15 | $10,297,573 | 1,129,779 (Indirect Direct) | View |
| 2025-08-11 Sale | 2025-08-13 5:33 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 46,463 | $355.32 | $16,509,032 | 1,159,847 (Indirect Direct) | View |
| 2025-07-18 Sale | 2025-07-22 5:08 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 1,000 | $350 | $350,005 | 1,163,047 (Indirect Direct) | View |
| 2025-07-16 Sale | 2025-07-18 4:11 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 29,101 | $353.19 | $10,278,098 | 1,214,167 (Indirect Direct) | View |
| 2025-01-24 Sale | 2025-01-27 5:07 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 648 | $335.24 | $217,236 | 1,112,202 (Indirect Direct) | View |
| 2025-01-17 Sale | 2025-01-17 7:05 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 1,689 | $273.41 | $461,789 | 1,112,850 (Indirect Direct) | View |
| 2024-04-08 Sale | 2024-04-10 8:53 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 2,676 | $245.99 | $658,258 | 1,191,103 (Indirect Direct) | View |
| 2024-04-03 Sale | 2024-04-05 8:50 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 73,888 | $243.92 | $18,022,588 | 1,425,808 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-09 Exercise | 2026-01-13 4:38 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 240 | $15.8 | 1,111,129 (Direct) | View |
| 2026-01-09 Exercise | 2026-01-13 4:38 pm | N/A 2027-03-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 240 | $0 | 1,111,129 (Direct) | View |
| 2026-01-09 Exercise | 2026-01-13 4:34 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 18,410 | $15.8 | 1,111,369 (Direct) | View |
| 2026-01-09 Exercise | 2026-01-13 4:34 pm | N/A 2027-03-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 18,410 | $0 | 1,111,369 (Direct) | View |
| 2025-12-10 Gift | 2025-12-12 4:35 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 5,455 | $0 | 1,129,779 (Direct) | View |
| 2025-12-10 Exercise | 2025-12-12 4:35 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 18,650 | $15.8 | 1,129,779 (Direct) | View |
| 2025-12-10 Exercise | 2025-12-12 4:35 pm | N/A 2027-03-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 18,650 | $0 | 1,129,779 (Direct) | View |
| 2025-08-11 Exercise | 2025-08-13 5:33 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 46,463 | $9.45 | 1,159,847 (Direct) | View |
| 2025-08-11 Exercise | 2025-08-13 5:33 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 46,463 | $0 | 1,159,847 (Direct) | View |
| 2025-07-18 Exercise | 2025-07-22 5:08 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 1,000 | $9.45 | 1,163,047 (Direct) | View |
| 2025-07-18 Exercise | 2025-07-22 5:08 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 1,000 | $0 | 1,163,047 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 4:11 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 29,101 | $9.45 | 1,214,167 (Direct) | View |
| 2025-07-16 Exercise | 2025-07-18 4:11 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Director | 29,101 | $0 | 1,214,167 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 5:00 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 11,763 | $0 | 1,123,965 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 8:53 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 2,676 | $9.45 | 1,191,103 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 8:53 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 2,676 | $0 | 1,191,103 (Direct) | View |
| 2024-04-03 Exercise | 2024-04-05 8:50 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 73,888 | $9.45 | 1,425,808 (Direct) | View |
| 2024-04-03 Exercise | 2024-04-05 8:50 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 73,888 | $0 | 1,425,808 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 5:54 pm | N/A 2031-01-23 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 14,504 | $0 | 1,129,043 (Direct) | View |
| 2024-01-16 Tax Withholding | 2024-01-18 1:46 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 1,546 | $243.92 | 1,108,753 (Direct) | View |
| 2023-01-16 Option Award | 2023-01-18 8:00 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 20,001 | $0 | 1,110,299 (Direct) | View |
Ownership | 2022-08-01 4:10 pm | 2021-03-29 2026-03-29 | BriaCell Therapeutics Corp. | BCTX | Taub Rebecca Director | 0 | $0 | 20,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 8:12 pm | N/A 2032-02-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca See Remarks | 61,500 | $0 | 61,500 (Direct) | View |